|
Market Closed -
Nasdaq
04:00:00 2026-10-02 pm EDT
|
5-day change | 1st Jan Change | ||
| 144.74 USD | -1.87% |
|
-4.10% | +17.92% |
| Oct. 02 | Legend Biotech Faces Pressure From Rivals Ahead of Key FDA Decision, UBS Says | MT |
| Sep. 28 | Mirum's liver infection drug lowers virus levels in late-stage study | RE |
| Market Cap | 179B 159B 149B 136B 256B 17,253B 258B 1,801B 698B 8,820B 674B 659B 28,307B | P/E 2026 * |
-43.8x | P/E 2027 * | 18x |
|---|---|---|---|---|---|
| Enterprise Value | 196B 174B 163B 148B 280B 18,863B 282B 1,969B 763B 9,643B 737B 721B 30,948B | EV / Sales 2026 * |
6.39x | EV / Sales 2027 * | 5.77x |
| Free-Float |
99.88% | Yield 2026 * |
2.27% | Yield 2027 * | 2.31% |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| GILD | Delayed | |
CBOE
| GILD | Real-time | |
Tradegate
| GIS | Real-time | |
Xetra
| GIS | Delayed | |
Mexican S.E.
| GILD * | End-of-day quote | |
Boerse Muenchen
| GIS | Real-time | |
Wiener Boerse
| GILD | End-of-day quote | |
Borsa Italiana
| 1GILD | End-of-day quote | |
Börse Stuttgart
| GIS | Delayed | |
Deutsche Boerse AG
| GIS | Delayed | |
London S.E.
| 0QYQ | Delayed | |
CBOE
| Real-time | ||
Santiago S.E.
| GILD | End-of-day quote | |
Swiss Exchange
| GILD | Delayed | |
Lima
| GILDUS | End-of-day quote | |
Santiago S.E.
| GILDCL | End-of-day quote | |
Swiss Exchange
| GILD | Delayed | |
CBOE
| 0QYQ | Real-time |
Last Transcript: Gilead Sciences, Inc.
| 1 day | -1.87% | ||
| 1 week | -4.10% | ||
| Current month | -2.89% | ||
| 1 month | -3.26% | ||
| 3 months | +10.26% | ||
| 6 months | +3.60% | ||
| Current year | +17.92% |
| 1 week | 144 | 152.74 | |
| 1 month | 142.94 | 154.2 | |
| Current year | 116.88 | 157.29 | |
| 1 year | 112.41 | 157.29 | |
| 3 years | 62.07 | 157.29 | |
| 5 years | 57.16 | 157.29 | |
| 10 years | 56.56 | 157.29 |
| Manager | Title | Age | Since |
|---|---|---|---|
Daniel O'Day
CEO | Chief Executive Officer | 61 | 2019-02-28 |
Andrew Dickinson
DFI | Director of Finance/CFO | 56 | 2019-10-31 |
Keeley Wettan
CMP | Compliance Officer | - | 2025-12-17 |
| Director | Title | Age | Since |
|---|---|---|---|
Kelly Kramer
BRD | Director/Board Member | 58 | 2016-08-18 |
| Director/Board Member | 73 | 2017-12-31 | |
Harish Manwani
BRD | Director/Board Member | 72 | 2018-05-08 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/22/26 | Exercice | Controller/Auditor | 5,214 | 0.0004% | ||
| 9/15/26 | Sell | Executive/Senior Manager | -3,000 | 0.0002% | ||
| 9/15/26 | Sell | Chief Financial Officer | -3,000 | 0.0002% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.87% | -4.10% | +30.92% | +95.33% | 179B | ||
| -0.61% | -3.43% | +39.40% | +112.31% | 1,019B | ||
| -1.02% | -5.60% | +37.67% | +65.02% | 617B | ||
| +1.11% | -0.58% | +11.10% | +77.28% | 464B | ||
| +0.34% | -3.01% | +61.21% | +40.71% | 356B | ||
| -0.95% | -4.05% | +21.60% | +39.37% | 333B | ||
| -1.46% | -2.89% | +11.84% | +24.60% | 267B | ||
| -1.35% | -5.43% | -4.69% | +8.40% | 244B | ||
| -1.04% | -2.79% | +35.52% | +51.34% | 218B | ||
| -0.50% | -1.68% | -32.98% | -60.94% | 166B | ||
| Average | -0.26% | -3.22% | +21.16% | +45.34% | 386.29B | |
| Weighted average by Cap. | +0.38% | -3.25% | +27.79% | +63.38% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 30.7B 27.28B 25.46B 23.21B 43.77B 2,951B 44.17B 308B 119B 1,509B 115B 113B 4,842B | 32.68B 29.04B 27.1B 24.7B 46.59B 3,142B 47.02B 328B 127B 1,606B 123B 120B 5,155B |
| Net income | -4.27B -3.8B -3.54B -3.23B -6.09B -411B -6.15B -42.9B -16.62B -210B -16.05B -15.7B -674B | 10.28B 9.13B 8.52B 7.77B 14.65B 988B 14.78B 103B 39.96B 505B 38.58B 37.74B 1,621B |
| Net Debt | 16.75B 14.88B 13.89B 12.66B 23.87B 1,610B 24.09B 168B 65.12B 823B 62.87B 61.51B 2,641B | 9.12B 8.11B 7.57B 6.9B 13.01B 877B 13.13B 91.57B 35.48B 448B 34.26B 33.51B 1,439B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-02 | $144.74 | -1.87% | 5,044,221 |
| 26-10-01 | $147.50 | -1.04% | 4,438,698 |
| 26-09-30 | $149.05 | -1.47% | 5,357,405 |
| 26-09-29 | $151.28 | -0.61% | 5,322,556 |
| 26-09-28 | $152.21 | +0.85% | 5,081,993 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GILD Stock
Select your edition
All financial news and data tailored to specific country editions


















